AstraZeneca taps Roche, Qiagen for new blood-based cancer drug tests

July 28, 2014 6:23 AM

16 0

AstraZeneca taps Roche, Qiagen for new blood-based cancer drug tests

LONDON (Reuters) - AstraZeneca has signed up Roche and Qiagen to develop two separate diagnostic tests, both using simple blood samples, to identify patients who will benefit from its lung cancer drugs.

Currently testing patients to see if their tumors contain genetic mutations that make them suitable for drug treatment involves collecting a sample of tissue by needle biopsy or during surgery.

Also read: Fake news warning label was not from Facebook

Read more

To category page

Loading...